In vivo toxicity study of a plant Phyllanthus amarus, in rat by Sirajudeen, K.N.S. et al.
, ;. ·.YUSrAKAAN K.AMPUS KESIHMAM 
• .... UNIVERSITI SAJNS MALAYSiA RUJUKAN, 
LAPORAN AKHIR PROJEK PENYELIDIKAN 
R & D JANGKA PENDEK 
U NI \ .. Ei\ S i .,-~ ~A l "'S ;\T"LAYSL.\ I 
D1 i FRP.-L·. 
I 
I I 0 "l -·: 1 .~ r L .. 
I 
•.) l 
I ' - .. l' o h 
4 
.ul · ~ \..' U 
r 1 ~ 1 •, ~!J.Jiau ~ ... l u ::t 1-'cr~,b..a.ltJ.U t 
"In vivo toxicity study of a plant Phyllanthus amarus, in rat" 
Investigators: 
Dr. K.N.S.Sirajudeen 
Prof. Madya Dr. Siti Amrah Sulaiman 
Prof. Madya Dr. M.Madhavan 
Prof. Madya Dr.Zabidah Ismail 
Grant No: 304/PPSP/6131166 
J 
1) 
2) 
SAHAGIAN PENYEUDIKAN & PEMBANGUNAN 
CANSELORI 
UNIVERSITI SAINS MALAYSIA 
Laporan Akhir Projek Penyelidikan Jangka Pendek 
Nama Penyelidik: 
Nama Penyelidik-Penyelidik 
Lain (Jika berkaitan) 
Dr. K.N.S.Sirajudeen 
PM. Dr. Siti Amrah Sulaiman 
PM. Dr. M. Madhavan 
PM. Dr. Zabidah Ismail 
USM J/P- 06 
............. .. .... ............... .. · -· ... ··· ·· ······ ·· -· ...... ... ...... ··-
.... ............... .. ······ ... .... .. ... . ...... . .. .. ... ... ...... ... ··· ··· .. . 
. ... .. ......... ... ... ..... . ... ... ... .. . . .. ... . .. . .. . .. .. .. .. ... .. . ... ... .. . 
Pusat Pengajian/PusaVUnit Pusat Pengajian Sains Perubatan 
3) Tajuk Projek: "In vivo toxicity study of a plant Phyllanthus amarus, in rat" 
(Kajian tosiksiti in vivo Phyllanthus amarus terhadap tikus) 
uSM J/P~ • 1 
BAHAGI I\N PFNYFL![)I K 1\N 
PUSAT PDiG.L\JIAf\1 SA,If\J S r •·~ ..;'L\T.l\N 
r-J 
r.x 
fl 
' -. 
P"'r"' ":;l-.: ,.., .. F) l 
. , ,-· . '"'" -·"' " eru ::;, tan, USi~1KK 
hCMO 
4) (a) Penemuan Projek/Abstrak 
(Pertu disediakan makluman di antara 100-200 perkataan di dalam Bahasa Malaysia dan Bahasa 
lnggeris. lni kemudiannya akan dimuatkan ke dalam l.aporan Tahunan Sahagian Penyelidikan & 
Pembangunan sebagai satu cara untuk menyampaikan dapatan projek tuan/puan kepada pihak 
Universiti). 
Separate sheets attached 
··························································································-················· 
.......................................................................................................... ······ ... 
············································································································ 
.................................................................................................................... 
....... ... ········· ..................... ········· ··············· ....................................... ········· 
............................................................................................................................ 
...... ... .... ........ ... ............. ... ...... ... ...... ........................ .......... ......................... ... .. . 
...................... ..... ......................... ·································································· 
............................................. ··········································································· 
................................................................................................................................... 
············································································································ 
.......................................................................................................... ······ ······ ... 
........................................................... .......................................... ··············· 
.................... ······ ....... ······ ............ ········· ................................... ······ ········· ... . 
······ ............................................................................ ···································· 
········· ........................................................................................... ············ 
······ ...................... ············································· ................... ······ ...... ······ .. . 
······ ...... ······ ............................................................................................. .. 
... ... ... .... ... ...... ... .... ... .... ...... ... ... ... .... ..... ... ... ············ ............ . 
USM J/P-06 - 2 
"Kajian tosiksiti in vivo Phyllanthus amarus terhadap tikus" 
ABSTRAK 
Pengenalan 
Di Malaysia dan juga di negara lain, Phyllanthus amarus (P. amarus), sejenis spesis 
pokok dari keluarga Euphorbiaceae digunakan oleh pengamal perubatan tradisional 
bagi merawat jaundis dan penyakit lain. Adalah dilaporkan efikasi spesis ini berbeza 
dari segi kawasan geografi dan kepelbagaian dan perbezaan ini banyak dikaitkan 
dengan kandungan bahan di dalamnya. Bagaimanapun, buat masa ini tiada kajian 
toksiksiti yang lengkap dengan dokumentasi dijalankan di Malaysia. 
Objektif 
Tujuan kajian awal ini ialah untuk menentukan kesan toksik, jika ada, juga profil 
keselamatan ekstrak daun berakues P. amarus yang diberikan secara oral ke atas 
hepar tikus dengan menaksirkan perubahan morfologi, biokimia dan histologi. 
Bahan dan metod 
Tikus Sprague-Dawley (berat 180-230 g) digunakan sebagai model haiwan untuk 
kajian ini. Untuk kajian toksiksiti akut, tikus jantan diberikan ekstrak daun akues P. 
amarus (5g/kg) dan untuk kajian toksiksiti kronik, tikus jantan dan betina diberikan 
dos· 100g, 400g dan 800g/kg selama 6 minggu. Haiwan kawalan juga disediakan 
tanpa diberikan sediaan ekstrak. Berat badan tikus diambil pada permulaan kajian 
dan berskala sehingga tamat kaiian. Selepas masa kajian (6 minggu), haiwan akan 
dikorbankan dan homogenat hepar tikus dianalisa untuk mendapatkan sebarang 
petanda biokimia kecederaan hepar, alanin transaminas (AL n. aspartat transaminas 
(AST), alkalin fosfatas (ALP), laktat dehidrogenas (LDH) dan jumlah protein serum. 
Sahagian hepar juga diambil untuk kajian histologi - mikroskopi ringan, kajian 
antigen nuklear sel proliferatif (PCNA) dan kajian apoptik dengan menggunakan Tag 
kitapop. 
Keputusan 
Pemberian akut ekstrak P. amarus (5g/kg) tidak memberikan sebarang tanda 
toksiksiti atau kematian. Manakala kajian toksiksiti kronik tiada menunjukkan 
perbezaan signifikan (P>0.05) dari segi berat badan juga petanda biokimia (ALT, 
AST, ALP, LDH dan jumlah protein) di antara haiwan kawalan dengan haiwan yang 
diberikan ekstrak P. amarus sepanjang masa kajian. Ekstrak P. amarus yang tiOak 
toksik dibuktikan oleh kajian histologi i.e. tiada kelihatan perbezaan di antara tikus 
kawalan dengan tikus yang memakan ekstrak P. amarus. 
Rumusan 
Pemberian akut ekstrak P. amarus pada dos 5g/kg tidak memberikan kesan toksik 
kepada hepar tikus. Kajian toksiksiti kronik pula menunjukkan tiada toksiksiti 
kumulatif seperti yang ditunjukkan oleh ~iada perubahan signifikan ke atas parameter 
yang dikaji, juga keputusan kajian histologi. 
Kata kunci: Phyllanthus amarus, ekstrak akues, hepar, toksiksiti, enzim petanda 
kajian histologi ' 
ABSTRACT 
Introduction: Phyllanthus amarus (P. amarus), a plant species of 
Euphorbiaceae family, is used as a folk medicine for jaundice and other diseases 
in Malaysia and other countries. The variation in their efficacy with geographical 
location and varieties has been reported which has been attributed to their 
constituent composition. But, so far no toxicity studies have been carried out on 
this plant with clear documentation, especially with those plants growing in 
Malaysia. 
Objective: The aim of this preliminary study was to determine the toxic side 
effects of aqueous extract of leaves of P. amaros (grown in Malaysia) following 
oral administration in rats by assessing the morphological, biochemical and 
histological changes. 
Materials & Methods: Sprague-Dawley rats weighing (180-230 grams) were 
used as animal models in this study. Aqueous extract of leaves of P. amarus was 
administered orally to male rats for acute toxicity study (5 gram I Kg body 
weight) and to the male and female rats for chronic toxicity study (at the doses of 
100, 400 and 800 mg/ Kg body weight/day for six weeks). Control of male and 
female rats was also maintained without plant extract administration. Body weight 
of the rats was taken initially and periodically once a week, till the end of 
experimental period. At the end of experimental period (6 weeks), the rats were 
sacrificed and analyzed for biochemical markers of liver injury - alanine 
transaminase (AL T), aspartate transaminase (AST), alkaline phosphatase (ALP), 
lactate dehydrogenase (LDH) and total protein in the serum collected and the 
marker enzymes were assayed in the homogenates of the rat liver. Liver sections 
were taken for histological studies; Light microscopy, proliferative cell nuclear 
antigen (PCNA) study and apoptotic study by using ApopTag kit. 
Results: Acute admininstration of P. amarus extract, orally, even at a dose of 
5 gram/Kg body weight) did. not produce any signs of toxicity or mortality. In the 
chronic study, no significant differences (p>0.05) were obserVed ·between the 
control and P. amarus extract administered rats in the body weight gain during 
the experimental period as well as in the biochemical markers analyzed (ALT, 
AST,ALP,LDH and total protein) in serum and liver homogenates. The non-toxic 
nature of P. amarus extract administration was confirmed by histological studies 
i.e., no observable changes were found between control and P.amarus extract 
administered rats. 
Conclusion: Acute oral administration of P.amarus extract is non-toxic to the rat 
liver, even at a dose of 5 gram /kg body weight. The chronic toxicity study of P. 
amarus extracts adm_ini~tration showe~ the absence of cum ulat1ve toxicity as 
reflected by the non-stgntficant change tn the parameters studied as well as from 
the results of the histological studies. 
Key words: Phy/lanthus amarus, Aqueous extract, Liver, Toxicity, Marker 
enzymes, Histological studies 
(b) Senaraikan Kata Kunci yang digunakan di dalam abstrak: 
Bahasa Malaysia Bahasa lnggeris 
Phyl/anthus amarus, Phyllanthus amarus, 
................................................ ········· 
ekstrak akues Aqueous extract 
............................. ························ 
hepar Liver 
............. ·················· ········· ... ········· 
toksiksiti Toxicity 
··························· ...... ············ ..... . 
enzim petanda Marker enzymes 
... ······ ......................... ········· ········· 
kajian histologi Histological studies 
............................................ ······ ... 
...... .................... ······ ... ········· ......... . 
...... ························ ····················· 
......... ······ ......... ······ ······ .............. . 
5) Output Dan F aedah Projek 
(a) Penerbitan (termasuk laporan/kertas seminar) 
(Sila nyatakan jenis. tajuk, pengarang, tahun terbitan dan di mana telah diterbitldibentangkan). 
The manuscript entitled " Toxicological investiation of aqueous extract of leaves of Phyllanthus 
amarus in rat" (herewith attached) is going to be sent for publication in Journal of Ethno 
Pharmacology 
~-· ~b~~ct ·fi.~;;; ih~ ·~;k · -~ii t;~ -~b~M~d·f~~ ~~~~~~ti~~- i~· th~· ~-~i~~ ·1 ou; N~ti~~~i · c~~1~;~~~~ 
on Medical Sciences, PPSP. USM 
···························-······························-········································································ 
··································································································································· 
·····························································································-··········· 
······································ ···························································································· 
........ ·········· ·············· ... 
·············· ··············-·· 
USM J/P-06 - 3 
(b) Faedah-Faedah Lain Seperti Perkembangan Produk, Prospek Komersialisasi 
Dan Pendaftaran Paten. 
(Jika ada dan jika per1u, slla guna kertas berasingan) 
.............................. ~.-~ ... ~ .. ~~~l •• ~~~ ••• ~ ...................................................................... . 
································································································································· 
································································································································· 
································································································································· 
........................................................................................................................................ 
•• • •• • ••. •. • •• • • •. ••• • .. .••• •• • •. .•• •• • •• • •.. ... . . . • • • •• • •. . I ..•••••••••....................•.....•••••............ : .....••...••• 
·····························-··································································································· 
(c) Latihan Gunatenaga Manusia 
-
i) Pelajar Siswazah: 
:::::::::::::::::::::::::::::::::::::::::;.z: .. ::::::::::::::::·.::::::·:::.::::: ... ::: 
··············· ... ········· ........................... ········· .............................. . 
ii) Pelajar Prasiswazah: 
············ ... ······ ············ ········· ················ ................................... . 
. . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . ~.·: .. .................................................... . 
/ 
....... ······ .................................................................................. . 
iii) Lain-Lain: 
... ······ ......... ···.; ................................................... . 
USM J/P-06 - 4 
6. Peralatan Yang Telah Dibeli: 
.......................... : J. r~~.~<=J ............................................................................. . 
. . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . 
···············································································-····································· 
·····················································································-······························· 
····················································································································· 
··············· ···················································································· ·················· 
...................................................................................................................... 
······························································· ······················································ 
·················································································································· ... 
····················································································································· 
···················.·································································································· 
·················· ································································································ ... 
UNTUK KEGUNAAN JAWATANKUASA PENYELIDIKAN UNIVERSITI 
········· ··········································································································· 
······························································· ····················································· 
····················· ... ···························································································· 
···················································································································· 
········· ····································-································································· ····· 
········· ······ ····································································································· 
TrrANGAN PENGERUSIProfessor Zabidi A 
J/K PENYEUDIKAN Chairman of Research 
PUSAT PENGAJIAN School of Med· &iences 
Hc·alth C mpus 
Unhyersiti Sains Malaysia 
16450 Kubang K.erian, 
KELANTAN. l\iALA YSIA. 
USM J/P-06 - 5 
~- \\·i'· \ l .. tllll 
-~04 I I iltff} 
:~O·t I iOOfl 
'ltl4 1''(1(111 
-~0-1 liOUtl 
~0-l 2.~0(1(1 
-~o-1 z:;uoo 
'HI-4 2biJOtl 
·~o-1 270011 
'HJ..i 2lJOUU 
~iH Y>t)(l(l 
I II' ""'·•h ( '"' "" 
ll>•nlntuL .. m 100·2 ( l.thllll II 
1 p •••.• ..,, .. ~- .... 2il(r\ 
rT.dtl.ltl ~ .. 
il·'t-nutllll..,lll :wo-t 
lrr.,huu \i 
i 
I 
I'Tj I'l'lljl•i-. 
l'l ")I I hi>; !(,r, 
L-'J'SI' hI'~ llht.i 
['I")P td31J(,() 
l'PSI' ol31lhi> 
PPSI' (d:, 1 H~o 
PPSJ' bl311{•b 
Pl'l.ll' u I'~ II <•b 
l'PSI' !, ! ·~I I Mi 
PI'S)' ld:~I16G 
l'I'SI' i:l';! lh() 
LNIVEHSITlSAINS MAl.A\'S!A 
JABXIAN m·:..l\IDAHARI 
K\T\U,lli.AN WANG Pf.N\'J;:UDJI-..AN GEltAN USl\·[(304) 
PEl\.\ XL\ l~HmEJ.ANJAAN S1::1HNGGA 3l.JAI\tUAlU 2005 
1<1\'1 
l<=vr 
l )tIll ill 
t9,RUO.OU 
0.00 
0.00 
tUIO 
r·e~lllllllkan 
i'mjt•k 
')] ll.llll 
·:oai.ilO 
·iOO.OO 
J 2. ~70.00 
1.220.00 
T.1juk Projt;k~ In Vivo To:xic.ily ShuJy ot' d Plt~nl Phyll.mthu•; 
.uuarus, in Rcll 
Tempoh: 01 Jul 01·- Hi\pl' 04 
No.Akaun: 30·VPPSP/6Dllo6 
Perbel.snjtt.tn P•~runluJ....an T.mg~ungdn 
Semcl!.o·l 
H&~y..rttn 
T.ahu11 
SE!IUolSd 
f'kumt•ttl Hin,~r.(• Semo1sd 
Tnlum l .. tlu 
:w~.oo :;1~.00 
4.73 29~.27 
:;mwo 
H,Y:r~.25 (2,56;\.25) 3,757.00 
702.0() 1,~18.01) 
P,pl,utj-1 
T.thun 
St•tno.tStl 
:i,757.UO 
H,1ki 
PmjPk 
5i:•.UO 
2'J5. ~7 
500.00 
(lJ,3.W.2:.) 
15HUJll 
·~.:.oo oo ~,5oo.oo :\,50o.oo 
-- - ··- ---· ... -- -- --·--·------ ____ ._ ____ . ··-·-..- -~--- -~- ·- -·------ -------··- -~ ·- --·. 
t9,Hon.oo 1c. .. o:q.9s 3.765.02 3,757.00 :~.7~7.oo s.o~ 
.:-.-:::---:~--~---...:~ ..... --:-:=;;.;~;.;.;-:-_:~:...:-· ..• ~: ... ~=-~~-::•:=-:-.;:::.:~~-~= ."!".-·~=;~...:.::..;_:-:-=o::---:-.. ~..:.- .... ...;::-':..--:...-;.-:::~~::·;;=.:"".=:..':..:..~-::""'-:::..;:.=.~~-:-.. -:: .. --":.·-~ 
TABLE OF CONTENTS 
ABSTRACT 
1 INTRODUCTION 
2 MATERIALS AND METHODS 
3 RESULTS 
4 DISCUSSION 
5. CONCLUSION 
ACKNOWLEDGEMENTS 
REFERENCES 
PAGE 
1 
3 
6 
12 
25 
27 
28 
29 
"Kajian tosiksiti in vivo Phyl/anthus amarus terhadap tikus" 
ABSTRAK 
Pengenalan 
Di Malaysia dan juga di negara lain, Phyl/anthus amarus (P. amarus), sejenis spesis 
pokok dari keluarga Euphorbiaceae digunakan oleh pengamal perubatan tradisional 
bagi merawat jaundis dan penyakit lain. Adalah dilaporkan efikasi spesis ini berbeza 
dari segi kawasan geografi dan kepelbagaian dan perbezaan ini banyak dikaitkan 
dengan kandungan bahan di dalamnya. Bagaimanapun, buat masa ini tiada kajian 
toksiksiti yang lengkap dengan dokumentasi dijalankan di Malaysia. 
Objektif 
Tujuan kajian awal ini ialah untuk menentukan kesan toksik, jika ada, juga profil 
keselamatan ekstrak daun berakues P. amarus yang diberikan secara oral ke atas 
hepar tikus dengan menaksirkan perubahan morfologi, biokimia dan histologi. 
Bahan dan metod 
Tikus Sprague-Dawley (berat 180-230 g) digunakan sebagai model haiwan untuk 
kajian ini. Untuk kajian toksiksiti akut, tikus jantan diberikan ekstrak daun akues P. 
amarus (5g/kg) dan untuk kajian toksiksiti kronik, tikus jantan dan betina diberikan 
dos 1 COg, 400g dan 800g/kg selama 6 minggu. Haiwan kawalan juga disediakan 
tanpa diberikan sediaan ekstrak. Berat badan tikus diambil pada permulaan kajian 
dan berskala sehingga tamat kaiian. Selepas masa kajian (6 minggu), haiwan akan 
dikorbankan dan homogenat hepar tikus dianalisa untuk mendapatkan sebarang 
petanda biokimia kecederaan hepar, alanin transaminas (AL T), aspartat transaminas 
(AST), alkalin fosfatas (ALP), laktat dehidrogenas (LDH) dan jumlah protein serum. 
Sahagian hepar juga diambil untuk kajian histologi - mikroskopi ringan, kajian 
antigen nuklear sel proliferatif (PCNA) dan kajian apoptik dengan menggunakan Tag 
kit apop. 
Keputusan 
Pemberian akut ekstrak P. amarus (5g/kg) tidak memberikan sebarang tanda 
toksiksiti atau kematian. Manakala kajian toksiksiti kronik tiada menunjukkan 
perbezaan signifikan (P>0.05) dari segi berat badan juga petanda biokimia (ALT, 
AST, ALP, LDH dan jumlah protein) di antara haiwan kawalan dengan haiwan yang 
diberikan ekstrak P. amarus sepanjang masa kajian. Ekstrak P. amarus yang tidak 
toksik dibuktikan oleh kajian histologi i.e. tiada kelihatan perbezaan di antara tikus 
kawalan dengan tikus yang memakan ekstrak P. amarus. 
Rumusan 
Pemberian akut ekstrak P. amarus pada dos 5g/kg tidak memberikan kesan toksik 
kepada hepar tikus. Kajian toksiksiti kronik pula menunjukkan tiada toksiksiti 
kumulatif seperti yang ditunjukkan oleh tiada perubahan signifikan ke atas parameter 
yang dikaji, juga keputusan kajian histologi. 
Kata kunci: Phyllanthus amarus, ekstrak akues, hepar, toksiksiti, enzim petanda, 
kajian histologi 
ABSTRACT 
Introduction: Phyllanthus amarus (P. amarus), a plant species of 
Euphorbiaceae family, is used as a folk medicine for jaundice and other diseases 
in Malaysia and other countries. The variation in their efficacy with geographical 
location and varieties has been reported which has been attributed to their 
constituent composition. But, so far no toxicity studies have been carried out on 
this plant with clear documentation, especially with those plants growing in 
Malaysia. 
Objective: The aim of this preliminary study was to determine the toxic side 
effects of aqueous extract of leaves of P. amarus (grown in Malaysia) following 
oral administration in rats by assessing the morphological, biochemical and 
histological changes in them. 
Materials & Methods: Sprague-Dawley rats weighing (180-230 grams) were 
used as animal models in this study. Aqueous extract of leaves of P. amarus was 
administered orally to male rats for acute toxicity study (5 gram I Kg body 
weight) and to the male and female rats for chronic toxicity study (at the doses of 
100, 400 and 800 mg/ Kg body weight/day for six weeks). Control of male and 
female rats was also maintained without plant extract administration. Body weight 
of the rats was taken initially and periodically once a week, till the end of 
experimental period. At the end of experimental period (6 weeks), the rats were 
sacrificed and analyzed for biochemical markers of liver injury - alanine 
transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP), 
lactate dehydrogenase (LDH) and total protein in the serum collected and the 
marker enzymes were assayed in the homogenates of the rat liver. Liver sections 
were taken for histological studies; Light microscopy, proliferative cell nuclear 
antigen (PCNA) study and apoptotic study by using ApopTag kit. 
Results: Acute admininstration of P. amarus extract, orally, even at a dose of 
5 gram/Kg body weight) did not produce any signs of toxicity or mortality. In the 
chronic study, no significant differences (p>0.05) were observed between the 
control and P. amarus extract administered rats in the body weight gain during 
the experimental period as well as in the biochemical markers analyzed (AL T, 
AST,ALP,LDH and total protein) in serum and liver homogenates. The non-toxic 
nature of P. amarus extract administration was confirmed by histological studies 
i.e., no observable changes were found between control and P. amarus extract 
administered rats. 
conclusion: Acute oral administration of P.amarus extract is non-toxic to the rat 
liver, even at a dose of 5 gram /kg body weight. The chronic toxicity studies of P. 
amarus extracts administration (of 100-800 mg/kg body wt) showed the absence 
of cumulative toxicity as reflected by the non-significant change in the 
parameters studied as well as from the results of the histological studies. 
Key words: Phyllanthus amarus, Aqueous extract, Liver, Toxicity, Marker 
enzymes, Histological studies 
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1. INTRODUCTION 
Herbal medicines has been used since ancient times. Most of the 
population of the underdeveloped and developing countries depend on some 
form of traditional medicine. Malaysia is one of the important nations of 
biodiversity in the world and enriched with natural plant resources(Muhamad bin 
Zakaria and Mustafa Ali Mohd, 1994). 
One of the plant genuses widely used traditionally for the treatment of 
different diseases is Phyllanthus (Family: Euphoribaceae) and is distributed in 
most tropical and subtropical countries and comprise approximately of 550-750 
species throughout the world. Among them, one of the most studied species is 
P.amarus and is widely used in Malaysia and other countries (Calixto et a/., 
1998; Muhamad bin Zakaria and Mustafa Ali Mohd, 1994). 
Some of the vernacular names of the plant include: Dukong anak (Malay), 
Kilanelli (Tamil), Bhumyamalakai (Sanskrit), Chanca piedra, Quebra pedra 
(Brazil). 
P. amarus has bitter, astringent, cooling, diuretic, stomachic, antiseptic, 
antiviral, antidiabetic, hypotensive, antinociceptive, febrifuge properties and is 
traditionally used in the treatment of jaundice, diarrhea, dysentery, diabetes, 
fevers, uro-genital diseases, ulcers and wounds (Santos eta/, 1995; Calixto eta/, 
1998). Recent years, a growing interest shown towards the Phyllanthus with 
respect to their potential on management of several diseases (Odetola and 
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Akojenu, 2000; Rajeshkumar et a/., 2002; Srividya and Periwal, 1995) More 
research was done on its antiviral effect. Some reports have shown the antiviral 
effect of this plant by reducing the dectectable hepatitis B surface antigen 
(HbsAg) of HBV positive patients (Thyagarajan eta/., 1988; Ott et al., 1997 ). But 
other studies like from China, Thailand , India showed the failure of P.amarus in 
eradicating the HbsAg in patients with chronic hepatitis B virus (Leelarasamee et 
a/, 1990; Wang et a/, 1991, Doshi et a/, 1997). The variation in the clinical effect 
of these studies has been attributed to many factors such as different species, 
differences in growing condition and different processing methods (Thyagarajan 
eta/., 2002; Wang, 2000). 
Usually herbal medicines are widely perceived by the public as being 
natural, healthful and free from side effects, but that is not 100 % true. Plants 
contain hundreds of constituents and some of them may elicit a toxic side effects. 
A number of studies exist reporting the toxic effect of herbal medicines (Shaw et 
a/., 1997; Kaplowitz, 1997; Calixto, 2000 ). Therefore efficacy and safety study 
should be performed in these herbs. 
Eventhough a large number of clinical trials has been done on P .amarus 
and reporting their benefits, so far no systematic toxicological investigation has 
been reported on this plant, especially the P. amarus growing in Malaysia. 
Since the efficacy of Phyllanthus species varies with geographical 
location and varieties and because of their constitutent compostion variation, the 
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P .amarus grown in Malaysia (widely used here as the folk medicine for jaundice) 
has to be ascertained for their biosafety by conducting acute and chronic 
toxicity study . 
So the aim of this preliminary study was an attempt to determine the toxic 
effects of aqueous extract of leaves of P. amarus (grown in Malaysia) following 
oral administration in rats by assessing the morphological, biochemical and 
histological changes. 
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2 MATERIALS AND METHODS 
2.1 Plant material 
P.amarus was collected from MARDI (Malaysian Agricultural Research 
and Development Institute, Telung, Bachok, Kelantan) during the months 
of July-October and identified by FRIM (Forest Research Institute of 
Malaysia, Kepong, Selangor). The aqueous extraction of P.amarus leaves 
was carried out at the Department of Pharmacology, School of Medical 
Sciences, Universiti Sains Malaysia. 
2.2 Preparation of plant extract 
The plant material was cleaned and the leaves were separated, oven 
dried at 50°C. Then macerated into dry powder. Approximately 4.5 grams 
of fine leaves powder of P.amarus were extracted with distilled water 
(2:25) using soxhlet apparatus. After extraction, concentrated by rotary 
evaporator at 65°C. Then transferred into a suitable container and freeze 
dried by freeze dryer. The yield of the final crude aqueous P. amarus 
extract was 6-9°k (-380 grams). The dried extract was stored in a 
desicator until its use. The extract was dissolved in distilled water to the 
desired concentration just before the study. 
2.3 Animal and experimental design 
Male and female Sprague-Dawley rats weighing (180-220 grams) were 
used as the experimental animal in this study and were obtained from 
Animal House Facility Unit, Health Campus, Universiti Sains Malaysia and 
acclimatized for one week prior to start the experiment. Animals were 
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housed in a standard cages at a temperature of 23±2°C, 45-55% relative 
humidity with a 12h light/12h dark cycle. The animals were fed with 
commercial pellet diet and water ad libitum. 
Our study protocol was approved by the animal ethical committee, Health 
Campus, Universiti Sains Malaysia. 
Two types of studies were carried out (WHO, 1993; Arnold, 1990) Acute 
and chronic study and in both studies the rats were administered with 
P.amarus extract by gavage (orally). 
2.4 Acute study 
Aqueous leaves extract of P .amarus at a single dose of 5g/Kg body weight 
was administered orally to two male rats. Another two male rats served as 
control (without P.amarus extract administration). The animals were 
observed carefully for any visible signs of toxicity and mortality 
immediately after dosing, at 4h, 24h intervals, during the recovery period 
of 48h and twice daily upto 14 days. After 14 days, the rats were sacrificed 
under ether anesthesia. A thorough autopsy was carried out and all 
organs were observed for any macroscopic changes. 
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2.5 Chronic study 
2.5.1 Animal groups 
For the chronic study, the animals were grouped (ten rats in each group) 
as follows 
Male rats 
Group I - Control 
Group II, Ill & IV - Rats 
administered with P.amarus 
extract at the doses of 100,400 
and 800 mg/Kg body wt/day 
for 6 weeks by gavage, 
respectively 
Female rats 
Group A -Control 
Group B, C & D - Rats 
administered with P. amarus 
extract at the doses of 100,400 
and 800 mg/Kg body wt/day 
for 6 weeks by gavage, 
respectively 
The animals were observed daily for any signs of morbidity and mortality 
and their body weights were measured periodically in the experimental 
period. 
2.5.2 Collection of serum and liver samples for an lays is 
At the end of the experimental period (6 weeks), after an overnight fasting, 
both the male and female rat controls and P .amarus extract administered 
groups were sacrificed by decapitation. Blood was collected, allowed to 
clot and then centrifuged at 3,000 rpm for 15 minutes. Serum samples 
were separated and used for biochemical analysis. The samples were 
stored at -80°C, if not used immediately. 
Liver tissues were excised and washed in ice-cold saline and an weighed 
amount was homogenized with 0.1 M Tris buffer at pH 7.4 under cold 
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condition. The supernatant of the liver homogenates was used for the 
biochemical estimations. 
A portion of the liver tissue of all the (control and P. amarus extract 
administered) groups were fixed in 1 0°/o formal saline for the histological 
studies. 
2.5.3 Biochemical analysis 
In the collected serum, the total protein and the activities of the liver 
marker enzymes such as AL T,AST,ALP and LDH were assayed by using 
standard kit (ALT Randox kit , Randox Total protein biuret reagent-
Randox Laboratories Ltd, UK; AST,ALP and LDH Roche Kits - Roche 
diagnostics, GmbH, Germany) in a Hitachi-912 autoanalyser available in 
our department of chemical Pathology, School of Medical Sciences, 
Universiti Sains Malaysia. 
Similarly the activities of the marker enzymes- ALT,AST, ALP and LDH 
were assayed in the liver homogenates prepared. 
2.5.4 Histological studies 
This study was carried out in the department of Pathology, School of 
Medical Sciences, Universiti Sains Malaysia. 
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A portion of all the liver specimens fixed in 1 0% formal saline were 
processed routinely overnight using histokinette. Then they were 
embedded in paraffin was. Three sections, each four micron in thickness 
were cut from each paraffin block. 
Light Microscopic study 
One section from each sample was stained with Haematoxylin & Eosin 
(H&E) stain by the standard method for light microscopic histological 
examination 
Proliferative Cell Nuclear Antigen (PCNA) study 
Another section from each sample was stained with anti PCNA (DAKO, 
Denmark) using standard immunohistochemistry procedure and the 
positivity was visualized with the chromogen diaminobenzidine (DAB) 
(DAKO, Denmark) and expressed in percentage. 
Apoptosis study 
The third section from each sample was assessed for apoptosis. They 
were stained with ApopTag -Apoptosis dectection kit {Chemicon, USA) 
whereby the reagents are designed to label the free 3'0H DNA termini in 
situ with chemically labelled and unlabelled nucleotides. The nucleotides 
contained in the Reaction Buffer are enzymatically added to the DNA by 
terminal deoxynucleotidyl transferase {TdT). TdT catalyzes a template-
independent addition of nucleotide triphosphates to the 3'0H ends of 
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double stranded or single stranded DNA. The incorporated nucleotides 
form an oligomer composed of digoxigenin-conjugated nucleotide and 
unlabelled nucleotide in a random sequence. The ratio of labelled to 
unlabelled nucleotide in ApopTag Peroxidase Kits is optimized to promote 
anti digoxigenin antibody binding. DNA fragments which have been 
labelled with digoxigenin-nucleotide are then allowed to bind an anti-
digoxigenin antibody that is conjugated with to a peroxidase reporter 
molecule. The bound peroxidase antibody conjugate enzymatically 
generates a permanent, intense, localized stain from chromogenic 
substance, providing sensitive detection in immunohistochemistry. This 
mixed molecular biological-histochemical system allows fro sensitive and 
specific staining of very high concentrations of 3'0H ends that are 
localised in apoptotic bodies. 
2.6 Statistical Analysis 
The results of the biochemical analysis are expressed as mean± S.D. for 
ten animals in each group. The difference between the control and 
P.amarus extract administered groups (for each sex of animals) have 
been analysed by student's t-test. p value <0.05 , considered as 
significant. 
1 1 
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3. RESULTS 
3.1 ACUTE STUDY 
During the course of the acute study, no treatment related effect was 
observed on the general condition or behaviour of the experimental 
animals. All the rats appeared to be normal, survived during the 
experimental period and none of them showed any visible signs of toxicity. 
A thorough autopsy of the P.amarus administered rats revealed no 
treatment related macroscopic changes. 
3.2 CHRONIC STUDY 
3.2.1 Body weight 
Mean body weight gain of the P .amarus extract administered groups (at 
the doses of 100,400 and 800 mg/Kg body weight/day) have shown no 
appreciable difference when compared to their control (both male and 
female rats) after 6 weeks duration of the study (Figure 1). 
The macroscopic appearance of all the organs observed was found to be 
normal and there were no appreciable changes in the liver weight of 
P.amarus extract administered groups and control group (data not shown). 
3.2.2 Biochemical study 
There were no significant differences (p>0.05) observed in the 
biochemical parameters studied (ALT,AST,ALP,LDH and total protein) in 
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the serum between controls and P.amarus extract administered groups (of 
both male and female) (Figure 2 & 3). 
Similarly, the parameters assayed (AL T ,AST ,ALP and LDH) in the liver 
homogenates of controls and P .amarus extract administered groups also 
showed no significant difference {p>0.05) (Figure 4 & 5). 
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Fig. 1 : Mean body weight gain of control and P. amarus administered 
groups, Male and Female rats at the end of experimental period 
Groups (male rats) 
Group I []Group II []Group Ill []Group IV 
Groups (Male rats) 
Group I -Control 
Group II, III and IV - Phy/lanlhus 
amarus extract administered groups at 
the doses of I OOmg/Kg body wt/day; 
400mg/Kg body wt/day; 800mg/Kg 
body wt/day, orally, for 6 weeks 
respectively 
Groups (female rats) 
jcGroup A CGroup B Ill Group C CGroup D I 
Groups (Female rats) 
Group A -Control 
Group B,C and D - P. amarus extract 
administered groups at the doses of 
I OOmg/Kg body wt/day; 400mg/Kg 
body wt/day; 800mg/Kg body wt/day , 
orally, for 6 weeks respectively 
Values are mean± S.D. for ten animals in each group & analyzed by Student's t-test. 
No significant changes in the mean body weight gain observed when P.amarus extract 
administered groups compared with control group (of both male and female rats). 
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Figure 2: Level of total protein and activities of serum marker enzymes of control 
and P. amarus extract administered groups (male rats) 
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Group II, III and IV- P. amarus 
extract administered groups at the 
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body wt/day, orally, for 6 weeks 
respectively 
Values are mean± S.D. for ten animals in each group and anaJyzed by Student' s t-test. 
Group IJ,lll and IV compared with Group I (contro l) and p value <0.05 considered significant. 
NS p>0.05- not significant 
15 
Figure 3: Level of total protein and activities of serum marker enzymes of control 
and P. amarus extract administered groups (female rats) 
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NS p>0.05- not significant 
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Figure 4: Activities of AL T, AST, ALP and LDH in the liver homogenates of control 
and P.amarus extract administered groups (male rats) 
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I Figure 5: Activities of ALT, AST, ALP and LDH in the liver homogenate of control 
and P. amarus extract administered groups (female rats) 
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3.3 Histological study 
3.3.3. Light microscopic study 
Histological examination of the liver under light microscope showed no 
significant pathological changes in the P. amarus extract administered 
groups (at the acute dose of Sg/Kg body weight and at the doses of 100, 
400 & 800 mg/Kg body wtJ day, orally, for six weeks to both male & female 
rats) (figures 8-14) when compared to their controls (Figures 6 & 7). 
(H&E) 
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3.3.2 PCNA Study 
Anti PCNA antibody was used to measure the proliferation of hepatocytes 
by immunohistochemistry. The cells that are in the proliferative pool shows 
brown colour staining (Figure 15). PCNA of liver from control rat was 
1.9% (Figures 16 & 17) and for the acute dose (5g/Kg body weight) 
P.amarus extract administered rat was 1.8% (Figure18). For the P.amarus 
extract administered groups at the doses of 100, 400 & 800 mg/Kg body 
wt1 day, orally, for 6 weeks (both male & female rat livers) showed PCNA 
of 0.2% -2.1% (Figures 19-24) which are similar to that of their controls. 
fig. l 7: Liver from control female rat shows o nly 
occasional cells in proliferative cycle (anti PCNA) 
4 
ffi 
Fig. l 6: Liver from control male rat shows only 
occasio nal cells in pro liferative cycle (anti PCNA) 
Fig. l 8: Liver from male rat with acute 
administratio n of P.amarus extract Sg!Kg body wt. 
shows on ly occasional cells in proliferative cycle 
(anti PCNA) 
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Fig.l9: Liver from male rat administered with P.amarus 
extract I 00 mg/Kg body wtl day for 6 weeks shows only 
occasional cells in proliferative cycle (anti PCNA) 
Fig.2 1: Liver from male rat administered with P.amarus 
extract 400 mg/Kg body wtl day for 6 weeks shows only 
occasio nal cells in proliferative cycle (anti PCNA) 
Fig.23: Liver from male rat administered with P.amarus 
extract 800 mg/Kg body wt/ day for 6 weeks shows only 
occasional cells in proliferative cycle (ant i PCNA ) 
Fig.20: Liver from female rat administered with P.amarus 
extract I 00 mg/Kg body wtl day for 6 weeks shows only 
occasional cells in proliferative cycle (anti PCNA) 
-
Fig.22: Liver from female rat administered with P.amarus 
extract 400 mg/Kg body wtl day fo r 6 weeks shows o nly 
occasional cells in proliferative cycle (anti PCNA) 
- 1 • -
~ • "I 
Fig.24: Liver from female rat administered w1"th p 
.amarus extra~t 800 m~g body wtl day fo r 6 weeks shows only 
occasiOnal cells tn pro liferative cycle (anti PCNA) 
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3.3.3 Apoptosis study 
Apoptosis in the liver was measured in the hepatocytes using ApopTag 
Kit. The positivity was indicated by the brown colour in nucleus (Figure 
25). Apoptosis in the livers from control (both male and female rats) were 
0.2% (Figure 26 &27). Apoptosis in the livers from P.amarus extract 
administered groups were ranged from 0.2% to 1.5% (Figures 28-34) 
which are similar to that of their controls. 
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Fig. 25: Apoptotic bodies are stained brown in a 
positive control slide (ApopTag kit) 
Fig. 27: Normal control female liver shows occasional 
apoptotic bodies (ApopTag kit) 
Fig. 26: Normal control male liver shows 
occasional apoptotic bodies (ApopTag kit) 
.. 
/, . 
Fig. 28: Male rat liver administered with acute P.amarus 
extract at a dose of 5g!Kg body wt, shows occasional 
apoptotic bodies (ApopTag kit) 
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Fig. 29: Liver from male rat administered with P.amarus 
extract I 00 mg!Kg body wt/ day for 6 weeks shows 
occasional apoptotic b~ies (ApopTag kit) 
(.' 
Fig. 3 1: Liver from male rat administered with P.amarus 
extract 400 mg!Kg body wt/ day for 6 weeks shows 
occasional ~p~_!~c bodi~s (ApopTag kit) 
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Fig. 33: Liver from male rat administered with P.amarus 
extract 800 mg/Kg body wt/ day for 6 weeks shows 
occasional apoptotic bodies (ApopTag kit) 
.. 
·- •• ; 
Fig. 30: Liver from female rats administered with 
P.amarus extract 100 mg!Kg body wt/ day for 6 weeks 
hows occasional apoptotic bodies (ApopTag kit) 
Fig.32: Liver from female rat administered with P.amarus 
extract 400 mg!Kg body wt/ day for 6 weeks shows 
occasional apoptotic bodies (ApopTag kit) 
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Fig. 34: Liver from female rat adm inistered w1'th p 
.amarus 
extract 800 mg/Kg body wt/ day for 6 weeks show 
occasional apoptotic bod ies (ApopTag kit) s 
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